Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Punch, shave and excision biopsy principles

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Escalate urgently when assessment for Punch, shave and excision biopsy principles reveals systemic toxicity, airway or eye involvement, extensive skin failure, a non-blanching eruption in an unwell patient, or a rapidly changing lesion suspicious for aggressive malignancy.

Synopsis

Choose punch, shave or excision biopsy according to the clinical question, obtain informed consent and a representative specimen, and prevent avoidable diagnostic and procedural harm.

  • Plan with the reporting question and suspected depth in mind: technique, site and orientation determine what the pathologist can assess.
  • Excision with an appropriate narrow clinical margin is generally used for suspected melanoma diagnosis when feasible; avoid superficial shave sampling that truncates depth.
  • Punch biopsy provides full-thickness cylindrical tissue from a selected focus, while shave biopsy samples superficial exophytic or epidermal lesions.
  • Confirm identity, allergies, anticoagulants, implanted devices, pregnancy where relevant, anatomical risk, consent, specimen container and result ownership before starting.
  • For Punch, shave and excision biopsy principles, describe what is seen before assigning a diagnosis, and record site, extent, symptoms, duration and change over time.
  • A technically adequate result in Punch, shave and excision biopsy principles can still be misleading when the wrong lesion, site, preparation or clinical question was selected.

Key red flags

Suspected melanoma, rapidly growing squamous malignancy, uncontrolled bleeding risk, infection at the procedural site or a lesion near critical anatomy requires appropriate specialist planning rather than an improvised biopsy.

Melanoma concern

Asymmetry, evolution, nodularity, ulceration or atypical pigment should trigger a melanoma-appropriate excision or specialist pathway.

Investigation priorities

01
Pre-procedure history and examinationFirst step

Choose a safe technique and representative target.

Management branches

Planned assessmentUse skin biopsy planning systematically

The patient is stable and the result will alter diagnosis, referral or follow-up.

  1. Define the question for Punch, shave and excision biopsy principles, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
  2. Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
  3. Interpret the result beside the full clinical pattern, communicate uncertainty and arrange ownership of results and safety-netting. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Guy's and St Thomas' NHS Foundation Trust skin biopsySkin-biopsy preparation, procedure, aftercare and result follow-up.
  • NICE NG14 melanoma assessment and managementDermoscopy, baseline photography and specialist assessment recommendations.
  • NICE NG12 suspected cancer recognition and referralUrgent referral features for suspected skin malignancy.
  • Worcestershire Acute Hospitals direct immunofluorescencePerilesional selection and special transport-medium requirements.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom